SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU CRYPTO is trending as its dedicated community relentlessly builds a 'permissionless brand' with expanding real-world products and a significant IRL presence. Holders are enthusiastically dollar-cost averaging, emphasizing the project's strong foundation and its unique potential to become a widely recognized name in the crypto ecosystem.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RAVE CRYPTO is experiencing a notable surge, with community discussion highlighting its recent record highs following an announced expansion with Trumps World Liberty Financial. The buzz indicates strong bullish sentiment, driven by recent short liquidations and a perception that this emerging token has significant upside potential without the burden of previous 'bag holders'.

Gold.com, Inc. engages in the trading of gold, silver, platinum, and palladium bullion numismatic coins, and related products. It operates through the following segments: Wholesale Trading and Ancillary Services, Direct-to-Consumer, and Secured Lending. The Wholesale Trading and Ancillary Services segment is involved in the distribution and purchasing of metal products from sovereign and private mints. The Direct-to-Consumer segment provides access to a multitude of products through its wholly owned subsidiaries. The Secured Lending segment includes coin and precious metal dealers, investors, and collectors. The company was founded by Steven C. Markoff on April 9, 1965 and is headquartered in El Segundo, CA.

Gold.com Inc.

Gold.com Inc. is trending as the commodity gold achieves new all-time highs, sparking intense community discussion around the company's role in the precious metals market. Investors are actively debating the reliability of physical gold holdings versus digital alternatives, particularly in this environment of rising prices. This occurs amid a broader "global repricing" of gold, fueled by significant central bank demand and shifting macroeconomic sentiment.

Dominion Energy, Inc. engages in the production and distribution of energy. It operates through following business segments: Dominion Energy Virginia, Dominion Energy South Carolina, Contracted Energy, and Corporate and Other. The Corporate and Other segment focuses on corporate, service company, non-controlling interest in Dominion privatization, and non-regulated retail energy marketing operations. The company was founded by William W. Berry in 1983 and is headquartered in Richmond, VA.

Dominion Energy Inc

Dominion Energy is trending due to the Trump administration's halt on offshore wind leases, including its Coastal Virginia project, sparking community debate over regulatory hurdles versus essential energy needs. Amidst this, significant discussion centers on Dominion's pivotal role in powering the burgeoning AI data center industry in Virginia, particularly with its exploration of Small Modular Reactors and recent partnerships. This creates a dual narrative for investors, weighing renewable energy's regulatory risks against substantial growth opportunities from increasing power demand.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is trending as reports surface about its exploration of acquiring premium coffee brands like Blue Bottle, signaling an ambitious global expansion beyond its dominant China market. This strategic shift and recent share movements by major investors are fueling a heated community debate, with many buying the perceived dip based on strong fundamentals, while others express frustration over persistent stock manipulation and uncertainty surrounding a potential relisting from the unregulated OTC market.

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Agios Pharmaceuticals Inc

Agios Pharmaceuticals is trending following FDA approval for Aqvesme, its treatment for anemia in alpha- or beta-thalassemia, making it the sole approved therapy for this rare blood disorder. While this represents a significant win with analysts adjusting price targets upwards, community discussion notes a mandated risk management program (REMS) requiring liver tests, with the drug's availability slated for early 2026.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle Mexican Grill is trending amidst its recent authorization of a substantial share repurchase program and the upcoming launch of new high-protein menu items. The community is actively discussing whether these catalysts, alongside recent tariff rollbacks, can reignite traffic and overcome concerns about valuation and competition within the fast-casual dining sector.

Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.

Kenvue Inc

Kenvue is trending amidst a pending acquisition offer from Kimberly-Clark, valuing its shares at $21.01, which has sparked arbitrage interest. However, community sentiment remains divided due to ongoing talc litigation and recent lawsuits alleging deceptive Tylenol marketing, despite some claims being called into question by health officials. This legal cloud introduces uncertainty, even as notable insider buying signals conviction in the company's long-term value.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is actively trending as it expands its anticoagulation pipeline with new acquisitions and advances its Phase 3-ready tecarfarin with an Abbott collaboration. The community is engaged in a polarized debate, highlighting the significant market opportunity for its novel therapies against persistent concerns regarding cash burn and potential dilutive financing needed for extensive clinical trials. Discussions revolve around its "Warfarin Replacement" potential and the impact of recent funding activities on the stock's trajectory.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is trending following promising preliminary Phase 3 open-label data indicating a significant reduction in breast cancer recurrence rates, which is driving substantial bullish sentiment. The community is actively discussing the therapy's expansive market potential and the strong confidence of insiders, fueling high anticipation for a potential short squeeze amidst extremely high borrow rates and a tight share float.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Evolus' (EOLS) "Hold" Rating Reaffirmed at Needham & Company LLC

Needham & Company LLC reaffirmed a "hold" rating on shares of Evolus in a research note on Wednesday...

Assenagon Asset Management S.A. Trims Position in Evolus, Inc. $EOLS

Assenagon Asset Management S.A. trimmed its stake in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 53.3% in the 3rd quarter, according to the company in its most recent filing with the Securities and...

2,435,550 Shares in Evolus, Inc. $EOLS Bought by Frazier Life Sciences Management L.P.

Frazier Life Sciences Management L.P. bought a new stake in Evolus, Inc. (NASDAQ:EOLS - Free Report) during the second quarter, according to the company in its most recent filing with the Securities...

Frontier Capital Management Co. LLC Buys 457,533 Shares of Evolus, Inc. $EOLS

Frontier Capital Management Co. LLC raised its stake in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) by 37.9% in the second quarter, according to the company in its most recent disclosure with...

Stonepine Capital Management LLC Has $8.44 Million Holdings in Evolus, Inc. $EOLS

Stonepine Capital Management LLC reduced its holdings in Evolus, Inc. (NASDAQ:EOLS - Free Report) by 19.2% during the 2nd quarter, according to its most recent disclosure with the Securities and...

Evolus, Inc. (NASDAQ:EOLS) Given Average Recommendation of "Hold" by Brokerages

Shares of Evolus, Inc. (NASDAQ:EOLS - Get Free Report) have been assigned an average rating of "Hold" from the five analysts that are covering the company, MarketBeat Ratings reports. One equities...

Evolus, Inc. $EOLS Position Cut by Connor Clark & Lunn Investment Management Ltd.

Connor Clark & Lunn Investment Management Ltd. lowered its position in shares of Evolus, Inc. (NASDAQ:EOLS - Free Report) by 85.7% in the 2nd quarter, according to its most recent disclosure with the...

Evolus (NASDAQ:EOLS) Posts Earnings Results, Misses Expectations By $0.10 EPS

Evolus (NASDAQ:EOLS - Get Free Report) released its earnings results on Wednesday. The company reported ($0.24) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by...

Evolus, Inc. (EOLS) Reports Q3 Loss, Beats Revenue Estimates

Evolus (EOLS) delivered earnings and revenue surprises of +26.32% and +1.70%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Prestige Consumer Healthcare (PBH) Q2 Earnings Expected to Decline

Prestige Consumer Healthcare (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau. The company was founded by Scott Cannizzaro in November 2012 and is headquartered in Newport Beach, CA.

Current Price	$6.85
Prev Close	$6.81
Open	$6.80
Dividend Yield	0.00%
50-Day Moving Average	$6.88
Beta	0.99
Avg. Volume	1.91M
PE Ratio	-7.51

52-Week High	$17.12
52-Week Low	$5.71
Market Capitalization	$441.42M
EPS (Annual)	-$0.813
Price to Book	-15.43
Revenue Per Employee	$802,030.12
Enterprise Value/EBITDA	N/A

EOLS
Evolus Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest EOLS News

EOLSEvolus Inc